Customer Publication

BCAP31, a cancer/testis antigen-like protein, can act as a probe for non-small-cell lung cancer metastasis

Authors: J. Wang et al.

Journal: Scientific Reports (2020)

Institution: the Fourth Military Medical University,

Research Areas: Cancer research

Cell Lines: A549, PLA-801D, GLC-82 (A549 - human lung adenocarcinoma cells; PLA-801D - lung giant cell carcinoma; GLC-82 - human papillomavirus-related endocervical adenocarcinoma)

Summary: In the absence of symptoms and effective screening programs, most lung cancers are diagnosed at advanced metastatic stages. Thus, in this study J. Wang with colleagues have explored how the metastasis mechanism (EMT) is involved in lung cancer development. Authors have demonstrated that B cell receptor-associated protein 31 (BCAP31) can be employed as a metastasis prognostic factor and used in therapeutic strategies for treating lung cancer. In this study, HoloMonitor M4 has been used to evaluate how BCAP31 protein affects cell migration, motility, optical thickness, and movement tracks. Additionally, the authors have studied the effects of BCAP31 amounts inside the cells on cell area.

Keywords: HoloMonitor M4, cell morphology and cell movements

Read the article …

Phase Holographic Imaging PHI AB
Skiffervägen 48
224 78 Lund
Sweden
+46 46 38 60 80
info@phiab.se

Phase Holographic Imaging PHI Inc.
265 Franklin Street Suite 1702
Boston, MA 02110
USA
+1 617-963-5150
info@phiab.com

Invoicing

VAT: SE556542781101
faktura@phiab.se

Securities Identification

ISIN: SE0005504636
LEI: 549300JZR79QYESM6296

HoloMonitor® is a registered trademark
Copyright © 2012-2021
Phase Holographic Imaging PHI AB

Phase Holographic Image logo in white

PHI Theme 3.12.2